-
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
-
Immunotherapy Improves Results in Head and Neck Cancer
Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
-
Controlling Cancer Without Surgery
Immunotherapy can induce a complete response in some people with mismatch repair-deficient cancers with solid tumors.
by Thomas Celona
-
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Consider Immunotherapy Before Surgery for Melanoma
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
Cancer Talk
Redefining Cancer Survivorship
As people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
by Thomas Celona
Family of Henrietta Lacks Works for ‘Health Intelligence’Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons